Business Wire - Teva Announces Tentative Approval of Buspirone HCL Tablets, 15mg
August 8, 2001 -- Business & Health Editors JERUSALEM--(BUSINESS WIRE)--Aug. 8, 2001 Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced today that the...
Canadian Corporate News - Biovail Reports Clinical Trial Results.
March 5, 2003 -- TORONTO, ONTARIO, Mar 5, 2003 (CCNMatthews via COMTEX) Biovail Corporation (NYSE:BVF)(TSX:BVF) -- Cardizem LA Phase IV results in...
Business Wire - Biovail Reports Clinical Trial Results
March 5, 2003 -- Business Editors/Health/Medical Writers TORONTO--(BUSINESS WIRE)--March 5, 2003 Biovail Corporation (NYSE:BVF)(TSX:BVF) -- Cardizem LA Phase IV...
Drug Store News - Mail-Order Rx chips away at retail sales
May 20, 2002 -- Mail-order drug sales are hot on the heels of retail. Of the $174.4 billion in prescription drugs dispensed last year, mail order claimed more than a...
Drug Store News - Teva's BuSpar tentatively approved
September 10, 2001 -- The Food and Drug Administration awarded tentative approval for buspirone HCl tablets 15 mg to Teva last month. With this approval, Teva has...
